SEC Filing Summary

Joseph A. Tyndall, a director at Axogen, Inc., was granted 4,392 Restricted Stock Units (RSUs) on June 24, 2026. This grant is an annual equity award for his service on the board. The RSUs are valued at $185,000 as of the grant date and will vest on June 24, 2027. Each RSU represents a contingent right to one share of Axogen, Inc. common stock. Following this transaction, Mr. Tyndall directly owns 4,392 shares of common stock underlying the RSUs.